Remove Biopharma Remove FDA Remove Medical science Remove Sales
article thumbnail

Bringing Therapies from Bench to Bedside: Navigating Challenges in the Last Mile

Clarify Health

After FDA-approval comes the last critical mile of this journey: bringing the product to market. Successfully launching a new product is no easy feat in the life sciences industry; up to 66% of newly launched drugs fail to meet market expectations within their first year. sales, medical science liaisons, etc.).

article thumbnail

Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

Medgadget

Human Xtensions chose to proceed with direct sales of its technology in the U.S. Interestingly, due to FDA’s regulatory methodology, surgical robots have to be approved for specific indications by the agency. Because of its tiny domestic market, Israeli firms typically end up joining large conglomerates.